H2020FP7HORIZON
Instituto de Medicina Molecular Joao Lobo Antunes
- Country
- PTPortugal
- Defence projects
- 0
- Projects, all programmes
- 69
- As coordinator
- 50
- EU contribution (CORDIS)
- EUR 34,789,230
- Active
- 2007 to 2025
Projects
69 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| SynapticMitochondriaQuality Control and Maintenance of Synaptic Mitochondria | H2020 | 2016 | Coordinator | EUR 1,300,000 |
| AXIAL.ECPRINCIPLES OF AXIAL POLARITY-DRIVEN VASCULAR PATTERNING | H2020 | 2016 | Coordinator | EUR 1,618,750 |
| TwinnToInfectUnleash IMM’s research excellence in immunity and infection through twinning to infect Lisbon and Portugal with its increase in competitiveness and innovation | H2020 | 2016 | Coordinator | EUR 893,500 |
| LDC4PCaTherBMX-targeted ligand-drug conjugates for prostate cancer therapy | H2020 | 2016 | Coordinator | EUR 160,636 |
| SynaNetNeurologic and Psychiatric Disorders: from synapses to networks | H2020 | 2016 | Coordinator | EUR 525,438 |
| ReTuBiTowards outstanding research and training in tumour biology at IMM | H2020 | 2016 | Coordinator | EUR 788,725 |
| REUSE4MALARIADrug Repurposing for Malaria Chemoprotection | H2020 | 2016 | Coordinator | EUR 145,500 |
| BIOSOCIOCOGOxytocin and Dopamine Interplay in Humans – on the Biology of Social Cognition | H2020 | 2015 | Participant | EUR 77,083 |
| GliaInnateSensingGlia-derived factors in innate lymphoid cell sensing and intestinal defence | H2020 | 2015 | Participant | EUR 1,125,257 |
| IL7sigNETureIL-7/IL-7R signaling networks in health and malignancy | H2020 | 2015 | Coordinator | EUR 1,988,125 |
| ProteinConjugatesA training network for the chemical site-selective modification of proteins: Preparation of the next-generation of therapeutic chemically-defined protein conjugates | H2020 | 2015 | Coordinator | EUR 741,939 |
| TREGenerationRepair of tissue and organ damage in refractory chronic graft versus host disease after hematopoietic stem cell transplantation by the infusion of purified allogeneic donor regulatory T lymphocytes | H2020 | 2015 | Coordinator | EUR 1,886,979 |
| DevoTed_miRMicroRNA determinants of the balance between effector and regulatory T cells in vivo | H2020 | 2015 | Coordinator | EUR 2,000,000 |
| ENLIGHT-TENEuropean Network linking informatics and genomics of helper T cells | H2020 | 2015 | Participant | EUR 476,713 |
| FAIR-PARK-IIConservative iron chelation as a disease-modifying strategy in Parkinson’s disease: a multicentric, parallel-group, placebo-controlled, randomized clinical trial of deferiprone | H2020 | 2015 | Participant | EUR 187,083 |
| INPACTInnovative peptides against cancer and pathogenic bacteria, with advances in science, biopharmaceutical drug development, product market targeting, training , and communication. | H2020 | 2015 | Coordinator | EUR 463,500 |
| GLYCOVAXA training network for the rational design of the next generation of well-defined glycoconjugate vaccines | H2020 | 2015 | Participant | EUR 238,356 |
| EXCELLtoINNOVLeverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection. | H2020 | 2015 | Coordinator | EUR 2,499,465 |
| MINDTHEGAPAdvanced Postdoctoral Training Programme | H2020 | 2014 | Coordinator | EUR 468,280 |
| PHONICSPositioning the nucleus for cell migration and muscle fiber function | FP7 | 2014 | Coordinator | EUR 1,968,000 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.